Cavalli A - Search Results

1

Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy.

Aristei C, Tarducci R, Palumbo I, Cavalli A, Corazzi F, Rulli A, Raymondi C, Latini P. Aristei C, et al. Among authors: cavalli a. Radiother Oncol. 2009 Jan;90(1):43-7. doi: 10.1016/j.radonc.2007.10.029. Epub 2007 Nov 26. Radiother Oncol. 2009. PMID: 18037180

2

Partial breast irradiation with interstitial high-dose-rate brachytherapy in early breast cancer: results of a phase II prospective study.

Aristei C, Palumbo I, Cucciarelli F, Cavalli A, Tarducci R, Raymondi C, Perrucci E, Cavaliere A, Latini P, Rulli A. Aristei C, et al. Among authors: cavalli a. Eur J Surg Oncol. 2009 Feb;35(2):144-50. doi: 10.1016/j.ejso.2008.06.002. Epub 2008 Jul 21. Eur J Surg Oncol. 2009. PMID: 18640810 Clinical Trial.

3

Individualized 3D-printed templates for high-dose-rate interstitial multicathether brachytherapy in patients with breast cancer.

Aristei C, Lancellotta V, Piergentini M, Costantini G, Saldi S, Chierchini S, Cavalli A, Di Renzo L, Fiorucci O, Guasticchi M, Bini V, Ricci A. Aristei C, et al. Among authors: cavalli a. Brachytherapy. 2019 Jan-Feb;18(1):57-62. doi: 10.1016/j.brachy.2018.09.007. Epub 2018 Nov 7. Brachytherapy. 2019. PMID: 30414715

4

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532).

Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano CV, Carbone GM, Cavalli A, Pagano F, Ragazzi E, Prayer-Galetti T, Alimonti A. Montopoli M, et al. Among authors: cavalli a. Ann Oncol. 2020 Aug;31(8):1040-1045. doi: 10.1016/j.annonc.2020.04.479. Epub 2020 May 6. Ann Oncol. 2020. PMID: 32387456 Free PMC article.

5

The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study.

Di Micco P, Tufano A, Cardillo G, Imbalzano E, Amitrano M, Lodigiani C, Bellizzi A, Camporese G, Cavalli A, De Stefano C, Russo V, Voza A, Perrella A, Prandoni P. Di Micco P, et al. Among authors: cavalli a. Viruses. 2021 Aug 30;13(9):1720. doi: 10.3390/v13091720. Viruses. 2021. PMID: 34578301 Free PMC article.

6

Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience.

Russo V, Cardillo G, Viggiano GV, Mangiacapra S, Cavalli A, Fontanella A, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Di Micco P. Russo V, et al. Among authors: cavalli a. J Cardiovasc Pharmacol. 2020 Oct;76(4):369-371. doi: 10.1097/FJC.0000000000000893. J Cardiovasc Pharmacol. 2020. PMID: 33027192

7

Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study.

Russo V, Cardillo G, Viggiano GV, Mangiacapra S, Cavalli A, Fontanella A, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Castaldo G, Di Micco P. Russo V, et al. Among authors: cavalli a. Front Med (Lausanne). 2020 Nov 27;7:569567. doi: 10.3389/fmed.2020.569567. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33330530 Free PMC article.

8

Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study.

Cardillo G, Viggiano GV, Russo V, Mangiacapra S, Cavalli A, Castaldo G, Agrusta F, Bellizzi A, Amitrano M, Iannuzzo M, Sacco C, Lodigiani C, Fontanella A, Di Micco P; FondenoxavidStudy Group. Cardillo G, et al. Among authors: cavalli a. J Blood Med. 2021 Feb 11;12:69-75. doi: 10.2147/JBM.S285214. eCollection 2021. J Blood Med. 2021. PMID: 33603528 Free PMC article.

9

A novel variant in the SUOX gene in the oldest individual with late-onset isolated sulfite oxidase deficiency.

Rizzi S, Cesaroni CA, Spagnoli C, Cavalli A, Pollazzon M, Caraffi SG, Dittadi C, Frattini D, Garavelli L, Fusco C. Rizzi S, et al. Among authors: cavalli a. Can J Neurol Sci. 2024 Dec 16:1-8. doi: 10.1017/cjn.2024.360. Online ahead of print. Can J Neurol Sci. 2024. PMID: 39676698 No abstract available.

10

Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.

Zuo F, Cao Y, Sun R, Wang Q, Simonelli L, Du L, Bertoglio F, Schubert M, Guerra C, Cavalli A, Hust M, Robbiani DF, Varani L, Abolhassani H, Xie XS, Hammarström L, Marcotte H, Pan-Hammarström Q. Zuo F, et al. Among authors: cavalli a. J Virol. 2024 Dec 4:e0174024. doi: 10.1128/jvi.01740-24. Online ahead of print. J Virol. 2024. PMID: 39629995 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

713 results

Search Page

Filters